John F Crowley Amicus Therapeutics, Inc. (FOLD) insider trading activity

John F Crowley is Executive Chairman of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 573,478 shares of FOLD, which is worth approximately $5.61 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 29,181 shares (Common Stock) at a price of $13.35 per share, resulting in proceeds of $389,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K

0% 3M change

37.14% 12M change

Total Value Held $5.61 Million

John F Crowley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	SELL Open market or private sale	$389,566 $13.35 p/Share	29,181 Reduced 4.84%	573,478 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$1,329,566 $14.0 p/Share	94,969 Reduced 13.61%	602,659 Common Stock
Feb 15 2024	SELL Open market or private sale	$436,589 $13.81 p/Share	31,614 Reduced 4.34%	697,628 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$273,621 $12.67 p/Share	21,596 Reduced 2.88%	729,242 Common Stock
Feb 01 2024	SELL Open market or private sale	$398,968 $12.62 p/Share	31,614 Reduced 4.04%	750,838 Common Stock
Jan 22 2024	SELL Open market or private sale	$683,841 $12.36 p/Share	55,327 Reduced 6.6%	782,452 Common Stock
Jan 16 2024	SELL Open market or private sale	$404,026 $12.78 p/Share	31,614 Reduced 3.64%	837,779 Common Stock
Jan 10 2024	SELL Open market or private sale	$431,531 $13.65 p/Share	31,614 Reduced 3.51%	869,393 Common Stock
Jan 09 2024	SELL Payment of exercise price or tax liability	$503,207 $13.65 p/Share	36,865 Reduced 3.93%	901,007 Common Stock
Jan 04 2024	SELL Payment of exercise price or tax liability	$143,256 $13.44 p/Share	10,659 Reduced 1.12%	937,872 Common Stock
Jan 03 2024	SELL Payment of exercise price or tax liability	$1,466,882 $13.53 p/Share	108,417 Reduced 10.26%	948,531 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	144,628 Added 12.04%	1,056,948 Common Stock
Dec 18 2023	BUY Grant, award, or other acquisition	-	34,572 Added 3.65%	912,320 Common Stock
Dec 15 2023	SELL Open market or private sale	$76,504 $12.66 p/Share	6,043 Reduced 0.68%	877,748 Common Stock
Dec 01 2023	SELL Open market or private sale	$66,956 $11.08 p/Share	6,043 Reduced 0.68%	883,791 Common Stock
Nov 15 2023	SELL Open market or private sale	$65,506 $10.84 p/Share	6,043 Reduced 0.67%	889,834 Common Stock
Nov 01 2023	SELL Open market or private sale	$66,302 $10.97 p/Share	6,044 Reduced 0.67%	895,877 Common Stock
Oct 16 2023	SELL Open market or private sale	$63,462 $10.5 p/Share	6,044 Reduced 0.67%	901,921 Common Stock
Oct 02 2023	SELL Open market or private sale	$68,901 $11.4 p/Share	6,044 Reduced 0.66%	907,965 Common Stock
Sep 15 2023	SELL Open market or private sale	$78,934 $13.06 p/Share	6,044 Reduced 0.66%	914,009 Common Stock
Sep 01 2023	SELL Open market or private sale	$78,451 $12.98 p/Share	6,044 Reduced 0.65%	920,053 Common Stock
Aug 15 2023	SELL Open market or private sale	$78,753 $13.03 p/Share	6,044 Reduced 0.65%	926,097 Common Stock
Aug 01 2023	SELL Open market or private sale	$80,687 $13.35 p/Share	6,044 Reduced 0.64%	932,141 Common Stock
Jul 17 2023	SELL Open market or private sale	$81,291 $13.45 p/Share	6,044 Reduced 0.64%	938,185 Common Stock
Jul 03 2023	SELL Open market or private sale	$74,401 $12.31 p/Share	6,044 Reduced 0.64%	944,229 Common Stock

Also insider at

NTLA

Intellia Therapeutics, Inc. Healthcare

Director

TRDA

Entrada Therapeutics, Inc. Healthcare

Director

JFC

John F Crowley

Executive Chairman

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account